These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 24212106)
1. Don't restrict funding from drug companies for doctors' education. Skolnik N BMJ; 2013 Nov; 347():f6452. PubMed ID: 24212106 [No Abstract] [Full Text] [Related]
2. When doctors go to class, industry often foots the bill: lectures tend to feature pills made by course sponsors; companies deny influence; a purple heartburn brochure. Hensley S Wall St J (East Ed); 2002 Dec; ():A1, A12. PubMed ID: 12653117 [No Abstract] [Full Text] [Related]
3. Physician preferences and attitudes regarding industry support of CME programs. Mueller PS; Hook CC; Litin SC Am J Med; 2007 Mar; 120(3):281-5. PubMed ID: 17349454 [No Abstract] [Full Text] [Related]
4. Clinician attitudes about commercial support of continuing medical education: results of a detailed survey. Tabas JA; Boscardin C; Jacobsen DM; Steinman MA; Volberding PA; Baron RB Arch Intern Med; 2011 May; 171(9):840-6. PubMed ID: 21555662 [TBL] [Abstract][Full Text] [Related]
5. [Financing of continuing education]. Kherad O; De Benedetti E; Perrier A Rev Med Suisse; 2015 Apr; 11(470):888. PubMed ID: 26050311 [No Abstract] [Full Text] [Related]
6. Do doctors rely on pharmaceutical industry funding to attend conferences and do they perceive that this creates a bias in their drug selection? Results from a questionnaire survey. Rutledge P; Crookes D; McKinstry B; Maxwell SR Pharmacoepidemiol Drug Saf; 2003 Dec; 12(8):663-7. PubMed ID: 14762982 [TBL] [Abstract][Full Text] [Related]
7. [Is it pertinent to investigate the relations between physicians and the drug industry]. Moliner J; Mozota J; Abad JM; Casaña L; Júdez D; Rabanaque MJ Rev Calid Asist; 2009 Apr; 24(2):72-9. PubMed ID: 19426930 [TBL] [Abstract][Full Text] [Related]
8. Relationships of physicians with pharmaceutical sales representatives and pharmaceutical companies: an exploratory study. Anadaleeb SS; Tallman RF Health Mark Q; 1996; 13(4):79-89. PubMed ID: 10159647 [TBL] [Abstract][Full Text] [Related]
9. Future directions in industry funding of continuing medical education. Steinbrook R Arch Intern Med; 2011 Feb; 171(3):257-8. PubMed ID: 21325116 [No Abstract] [Full Text] [Related]
10. Medical education companies got $170m in grants from 14 drug firms in 2010, study finds. Kmietowicz Z BMJ; 2013 Dec; 347():f7534. PubMed ID: 24353103 [No Abstract] [Full Text] [Related]
11. AMA forges ahead. Unveiling of educational campaign paid by drug industry triggers new criticism. Romano M Mod Healthc; 2001 Sep; 31(37):22-3. PubMed ID: 11573355 [No Abstract] [Full Text] [Related]
12. Indirect payments from drug companies to doctors for CME courses will be exempt from database. Hawkes N BMJ; 2014 Nov; 349():g6676. PubMed ID: 25378344 [No Abstract] [Full Text] [Related]
13. Industry funding for continuing medical education: is it ethical? Heaphy DP; Marrow VB Arch Ophthalmol; 2004 May; 122(5):771-3. PubMed ID: 15136327 [No Abstract] [Full Text] [Related]
14. Financial support of continuing medical education. Steinbrook R JAMA; 2008 Mar; 299(9):1060-2. PubMed ID: 18319417 [No Abstract] [Full Text] [Related]
15. Doctors, drug companies and medical ethics: a Sri Lankan perspective. Malavige GN Indian J Med Ethics; 2004; 1(1):26. PubMed ID: 16370067 [No Abstract] [Full Text] [Related]
16. Drug company sponsorship of education could be replaced at a fraction of its cost. Moynihan R BMJ; 2003 May; 326(7400):1163. PubMed ID: 12775595 [No Abstract] [Full Text] [Related]
17. Federal plan for prescriber education on opioids misses opportunities. Becker WC; Fiellin DA Ann Intern Med; 2012 Aug; 157(3):205-6. PubMed ID: 22868838 [No Abstract] [Full Text] [Related]
18. Commercial support for continuing medical education. Mamdani MB; Mamdani B Issues Med Ethics; 1997; 5(2):43-5. PubMed ID: 16267900 [No Abstract] [Full Text] [Related]
19. Continuing medical education: ethical collaboration between sponsor and industry. Wilson FS Clin Orthop Relat Res; 2003 Jul; (412):33-7. PubMed ID: 12838049 [TBL] [Abstract][Full Text] [Related]
20. In article, doctors back ban on drug companies' gifts; concerns cited on quality of patient care. Harris G N Y Times Web; 2006 Jan; ():A14. PubMed ID: 16450472 [No Abstract] [Full Text] [Related] [Next] [New Search]